IP Group has poured more funding into Istesso, whose treatment for rheumatoid arthritis traces its roots to an Aberdeen spinout, to drive immuno-metabolism therapies for autoimmune diseases.

Social security insurer Apicil and real estate holding company Reech Corporations Group have put up $11.3m for an insurance technology fund.

10X Genomics has purchased genomic analysis platform Spatial Transcriptomics, based on research at Karolinska Institute and KTH Royal Institute of Technology.

SoftBank Vision Fund has hired Kirthiga Reddy as a Silicon Valley-based venture partner and Carolina Brochado for its London office.

ICL-founded Accunea hopes to commercialise a medical device enabling clinicians to catch acute kidney injuries earlier than currently possible.

Cosmetic brand L'Oréal's Bold Business Opportunities for L’Oréal Development has already made its first investment, in online fragrance creator Sillages Paris.

Chalmers Ventures has again supplied smart lock supplier Parakey with funding after investing alongside IoT and wireless tech firm Qamcom in 2016.

Asgard Therapeutics will develop cancer therapies which use reprogrammed human skin cells to improve the immune system’s capacity to identify cancerous particles.

Kazanah Nasional is reportedly blocking emergency funding for the Qualcomm-backed AR technology developer, which has raised some $137m while trying to locate a sustainable business model.

Kozo Keikaku Engineering and BayBG were among the investors in a round that took the indoor mapping technology developer's total funding past $45m.